MARKET WIREFintel • 9d ago
Zepp Health Corporation - Depositary Receipt Price Target Decreased by 29.06% to $44.74Why ZEPP Stock dropped -3.85% Today — RQD Quant Desk Flash
$2.25 -3.85% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $2.23
Zepp Health Corporation each representing sixteen (Class A) (ZEPP) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $33.0M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $2.23 (-0.88%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D+
Each axis scored 0–20
12M PRICE TARGET CONE-10.2% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ZEPP)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (35/100 Composite)
🔍 WHY ZEPP SCORES 35/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+13/20 pts (37% of score)
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 12 (OVERSOLD (<32))
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (23% of score)
Altman Z-Score 0.33 (DISTRESS RISK (<1.8)) • Piotroski F-Score 5/9
▼ #1 Drag / Risk Factor: Cash Engine Quality4/20 pts (-16 pt drag)
Capital intensity & 0% operating margin leave 16 pts on the table
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$3.72-18.8% Next Q
43
Q2 (-2Q)Grade D$3.02-13.6% Next Q
40
Q3 (-1Q)Grade E$2.61-13.8% Next Q
38
CurrentGrade D-$2.25-8.5% Hist 90D α
35
Trajectory: D (43) → D- (35)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a ZEPP Turnaround Squeeze
While ZEPP currently carries a cautious 35/100 (D-) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Technology with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.96) and Max Pain ($2.36) forces dealer call-delta covering toward $44.47.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $ZEPP• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ZEPP Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ZEPP Stock dropped -3.85% Today — RQD Quant Desk Flash
Zepp Health Corporation each representing sixteen (Class A) (ZEPP) dropped -3.85% to $2.25, trading at 2% of its 52-week range ($2.15 – $42.35). Stretched risk/reward at current multiples (-15% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($2.15 – $42.35) with RSI-14 at 12 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.25 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 38.3% gross margin and $0 annual free cash flow.
Live ZEPP Headlines & Catalysts
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ZEPP)
- ✓Walkthrough of ZEPP's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ZEPP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -87.12%🛡️ HOLDING TREND SUPPORT
2026-10-30O $2.16H $2.25L $2.15C $2.25VOL 112.6K
RES: $6.64SUP: $1.76SMA50: $3.96SMA200: $10.17
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ZEPP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +41.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ZEPP today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ZEPP. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ZEPP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ZEPP)
Technology Rank #624 of 714
⚔️ OSS vs ZEPP Full Matrix →
1. Head-to-Head Technology Peer Comparison (ZEPP vs. OSS, SCKT, XNDU, OMCL)
Industry: Computer Manufacturing (9 Tracked Issuers)Across 714 tracked Technology securities in the Roarable RQD universe, Zepp Health Corporation each representing sixteen (Class A) (ZEPP) ranks #624 by composite RQD confidence (35/100, grade D-) and #584 by equity capitalization ($33.0M). Within this direct 5-issuer industry benchmark cohort, OSS leads on earnings valuation at 28.6x trailing P/E, while OMCL leads on capital efficiency and profitability with 0.4% ROIC and 42.5% gross margin. OMCL currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with ZEPP at 35/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ZEPP
ACTIVE
Zepp Health Corporation each representing sixteen (Class A) | D- | 35/100 | — | 38.3% | -14.7% | -3.85% | $33.0M | Benchmark Subject |
| OSS One Stop Systems Inc. | D | 47/100 | 28.6x | 49.6% | -18.0% | -6.88% | $145.7M | /oss-vs-zepp → |
| SCKT Socket Mobile Inc. | D- | 40/100 | — | 49.7% | -35.0% | +5.94% | $3.0M | /sckt-vs-zepp → |
| XNDU Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares | D | 49/100 | — | — | — | -3.11% | $946.1M | /xndu-vs-zepp → |
| OMCL Omnicell Inc. ($0.001 par value) | C- | 61/100 | — | 42.5% | 0.4% | +2.59% | $1.68B | /omcl-vs-zepp → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001720446In its most recent audited fiscal period (FY2025, filed 2025-12-31), Zepp Health Corporation each representing sixteen (Class A) (ZEPP) reported GAAP revenue of $258.9M (+41.8% vs. FY2024 revenue of $182.6M , and -26.6% cumulative change since FY2023) , GAAP net income of -$40.1M, operating cash flow of -$25.7M, and free cash flow of -$26.2M (-1.6% YoY). On the balance sheet, ZEPP closed FY2025 with $564.8M in total assets against $0 in total debt (Altman Z-Score: 0.33, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $258.9M | -$40.1M | -$25.7M | -$26.2M | $564.8M | — |
| FY2024 (FY) | 2024-12-31 | $182.6M | -$75.7M | -$24.4M | -$25.8M | $528.6M | — |
| FY2023 (FY) | 2023-12-31 | $352.9M | -$31.0M | $42.6M | $42.6M | — | — |
3. ZEPP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ZEPP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Zepp Health Corporation each representing sixteen (Class A) (NYSE: ZEPP) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.25 (-3.85% 1D, market cap $33.0M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 714 tracked Technology issuers, ZEPP ranks #624 in composite RQD confidence.
How does ZEPP compare to OSS and SCKT in the Technology sector?
Within the Technology sector (Computer Manufacturing), ZEPP carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 38.3%, and ROIC of -14.7%. By comparison, OSS (One Stop Systems Inc.) holds a D grade (47/100 RQD, P/E 28.6x, ROIC -18.0%, cap $145.7M) and SCKT (Socket Mobile Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $3.0M). Among the 5-stock peer group, OSS leads on earnings multiple (28.6x) while OMCL leads on capital efficiency (0.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ZEPP?
Per ZEPP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001720446), Zepp Health Corporation each representing sixteen (Class A) generated $258.9M in revenue (+41.8% YoY), -$40.1M in net income, and -$26.2M in free cash flow against $564.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ZEPP trading relative to its 50-day, 200-day, and 52-week technical levels?
ZEPP last traded at $2.25 (-3.85% on volume of 68,747 shares), positioning the stock -43.18% below its 50-day simple moving average ($3.96) and -77.88% below its 200-day simple moving average ($10.17). Across its 52-week range of $2.15 to $42.35, ZEPP sits at the 0.2% percentile with a 14-day RSI of 11.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.97 to $2.53).
ZEPP Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ZEPP stock moving today?
Why ZEPP Stock dropped -3.85% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-15% return on capital) under elevated 10-year interest-rate pressure.